Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses
Xiang Liu, Zujian Feng, Changrong Wang, et al.
Biomaterials (2019) Vol. 230, pp. 119649-119649
Closed Access | Times Cited: 122

Showing 26-50 of 122 citing articles:

Colorectal cancer vaccines: The current scenario and future prospects
Wenqing Jia, Tao Zhang, Haiyan Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy
Liuzhou Mao, Panqin Ma, Xi Luo, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 9826-9849
Closed Access | Times Cited: 35
Potential roles and molecular mechanisms of bioactive ingredients in Curcumae Rhizoma against breast cancer
Peng Zhao, Jianfei Qiu, Chaolan Pan, et al.
Phytomedicine (2023) Vol. 114, pp. 154810-154810
Closed Access | Times Cited: 24
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Fluorinated Organic Polymers for Cancer Drug Delivery
Jingrui Xin, Xue Lu, Ji-Min Cao, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 15
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 13
Programmable prodrug micelle with size-shrinkage and charge-reversal for chemotherapy-improved IDO immunotherapy
Liangliang Dai, Xiang Li, Mengjiao Yao, et al.
Biomaterials (2020) Vol. 241, pp. 119901-119901
Closed Access | Times Cited: 69
Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy
Kandasamy Saravanakumar, Anbazhagan Sathiyaseelan, Arokia Vijaya Anand Mariadoss, et al.
Carbohydrate Polymers (2020) Vol. 245, pp. 116407-116407
Closed Access | Times Cited: 58
Emerging nanomedicines for effective breast cancer immunotherapy
Amirhossein Bahreyni, Yasir Mohamud, Honglin Luo
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 58
Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma
Changrong Wang, Xiaoguang Shi, Huijuan Song, et al.
Biomaterials (2020) Vol. 268, pp. 120579-120579
Closed Access | Times Cited: 54
Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 844-875
Open Access | Times Cited: 34
Unified Therapeutic‐Prophylactic Vaccine Demonstrated with a Postoperative Filler Gel to Prevent Tumor Recurrence and Metastasis
Dinglingge Cao, Wen Guo, Caiyun Cai, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 40
Closed Access | Times Cited: 32
Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
Xingliang Fang, Huanrong Lan, Ketao Jin, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3842-3842
Open Access | Times Cited: 31
Supramolecular Polymer‐Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage‐Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti‐Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma
Xiang Liu, Yini Huangfu, Jing-Rong Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 21
Recent progress of hydrogel-based local drug delivery systems for postoperative radiotherapy
Yandong Xie, Mingxi Liu, Chang Cai, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
“Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity
Lingjun Xiao, Louqian Zhang, Ciliang Guo, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 791-832
Open Access | Times Cited: 8
Nanodrugs based on co-delivery strategies to combat cisplatin resistance
Qiubo Wang, Hui Li, Wu Taixia, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 14-42
Closed Access | Times Cited: 7
Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy
Zohreh Jahanafrooz, Fatemeh Oroojalian, Ahad Mokhtarzadeh, et al.
Drug Development Research (2024) Vol. 85, Iss. 5
Closed Access | Times Cited: 6
Nanosystems for Improved Targeted Therapies in Melanoma
Cristina Beiu, Călin Giurcăneanu, Alexandru Mihai Grumezescu, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 318-318
Open Access | Times Cited: 48
Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
Farid A. Badria, Mithun Rudrapal, Shubham J. Khairnar, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 42
The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
Kuba Retecki, Milena Seweryn, Agnieszka Graczyk‐Jarzynka, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6012-6012
Open Access | Times Cited: 39
Preclinical models and technologies to advance nanovaccine development
Carina Peres, Ana I. Matos, Liane I.F. Moura, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 148-182
Closed Access | Times Cited: 33
Inhibition of tumor recurrence and metastasis via a surgical tumor-derived personalized hydrogel vaccine
Yi Lu, Chenghu Wu, Yanyan Yang, et al.
Biomaterials Science (2022) Vol. 10, Iss. 5, pp. 1352-1363
Closed Access | Times Cited: 27
Nanotechnology-based multifunctional vaccines for cancer immunotherapy
Xiaoxue Xie, Ting Song, Yi Feng, et al.
Chemical Engineering Journal (2022) Vol. 437, pp. 135505-135505
Closed Access | Times Cited: 23
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Jingjing Wang, Li Li, Zhi Ping Xu
Small Methods (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16

Scroll to top